A multicenter explainable machine learning analysis of autoimmune disease comorbidity in ankylosing spondylitis.
Source check: Source checked. Not independent scientific confirmation.
Finding: Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection. Learned LightGBM classification and SHAP produce clinical comorbidity classification and feature attribution; retrospective claims only. Testing: Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.
Technology: Learned LightGBM classification and SHAP produce clinical comorbidity classification and feature attribution; retrospective claims only.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned LightGBM classification and SHAP produce clinical comorbidity classification and feature attribution; retrospective claims only.
- Test and result
- Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection.
- Limitation / still unknown
- Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1775877/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.